Mechanisms of recovery from experimental autoimmune encephalomyelitis: T cell deletion and immune deviation in myelin basic protein T cell receptor transgenic mice

Journal of Neuroimmunology

Volumn 82, Issue 2, 1998, Pages 149-159

  Chen, Youhai ^a   Hancock, Wayne W ^b   Marks, Reinhard ^a   Gonnella, Patricia ^a   Weiner, Howard L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Autoimmune encephalomyelitis; Myelin basic protein; T cell receptor transgenics; Tolerance

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; HELPER CELL; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REMISSION; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; BRAIN; CELL COUNT; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNE SYSTEM; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELIN BASIC PROTEINS; RECEPTORS, ANTIGEN, T-CELL; REMISSION, SPONTANEOUS; SPLEEN; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0031891953     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00193-8     Document Type: Article

References (35)

1. Al-Sabbagh A., Miller A., Santos L.M.B., Weiner H.L. Antigen-driven tissue-specific suppression following oral tolerance: Orally administered myelin basic protein suppresses proteolipid induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur. J. Immunol. 24:1994;2104-2109.
2. Baron J.L., Madri J.A., Ruddle N.H., Hashim G., Janeway C.A. Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:1993;57-68.
3. Bluestone J.A. New perspectives of CD28-B7-mediated T cell costimulation. Immunity. 2:1995;555-559.
4. Burstein H.J., Abbas A.K. In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen. J. Exp. Med. 177:1993;457-463.
5. 1) cells. J. Immunol. 148:1992;3687-3691.
6. Chen Y., Kuchroo V.K., Inobe J.-I., Hafler D.A., Weiner H.L. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
7. Chen Y., Inobe J.-I., Marks R., Gonnella P., Kuchroo V.K., Weiner H.L. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature. 376:1995;177-180.
8. Chen Y., Inobe J.-I., Weiner H.L. Induction of oral tolerance to myelin basic protein in CD-8 depleted mice: Both CD4+ and CD8+ T cells mediate active suppression. J. Immunol. 156:1995;910-916.
9. Chen Y., Inobe J.-I., Kuchroo V.K., Baron J.L., Janeway C.A., Weiner H.L. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: Suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc. Natl. Acad. Sci. USA. 93:1996;388-391.
10. Correale J., Gilmore W., McMillan M., Li S., McCarthy K., Le T., Weiner L.P. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J. Immunol. 154:1995;2959-2968.
11. Friedman A., Weiner H. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA. 91:1994;6688-6692.
12. Goverman J., Woods A., Larson L., Weiner L., Hood L., Zaller D. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell. 72:1993;551-560.
13. Hancock W.W., Polanski M., Zhang Z.J., Blogg N., Weiner H.L. Suppression of insulitis in NOD mice by oral insulin administration is associated with selective expression of IL-4, IL-10, TGF-β and prostaglandin-E. Am. J. Pathol. 147:1995;1193-1199.
14. Hardin J.A., Sherr D.H., DeMaria M., Lopez P.A. A simple fluorescence method for surface antigen phenotyping of lymphocytes undergoing DNA fragmentation. J. Immunol. Methods. 154:1992;99-107.
15. Higgins P., Weiner H.L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 140:1988;440-445.
16. Karpus W., Swanborg R. CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor beta. J. Immunol. 146:1991;1163-1168.
17. Karpus W., Peterson J., Miller S. Anergy in vivo: Down-regulation of antigen-specific CD4+ Th1 but not Th2 cytokine responses. Int. Immunol. 6:1994;721-730.
18. Kerlero de Rosbo N., Milo R., Lees M.B., Burger D., Bernard C.C.A., Ben-Nun A. Reactivity to myelin antigens in multiple sclerosis: Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J. Clin. Invest. 92:1993;2602-2608.
19. Khoury S.J., Hancock W.W., Weiner H.L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis as associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176:1992;1355-1364.
20. Kuchroo V.K., Martin C.A., Greer J.M., Ju S.-T., Sobel R.A., Dorf M.E. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151:1993;4371-4382.
21. Kuchroo V., Das M., Brown J., Ranger A., Zamvil S., Sobel R., Weiner H., Nabavi N., Glimcher L. B7-1 and B7-2 costimulatory molecules differentially activate the TH1/TH2 developmental pathways: Application to autoimmune disease therapy. Cell. 80:1995;707-718.
22. Lafaille J., Nagashima K., Katsuki M., Tonegawa S. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell. 78:1994;399-408.
23. Levine S., Sowinski R., Steinetz B. Effects of experimental allergic encephalomyelitis on thymus and adrenal relation to remission and relapse. Proc. Soc. Exp. Biol. Med. 165:1980;218-224.
24. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today. 16:1995;34-38.
25. Marrack P., Hugo P., McCormack J., Kappler J. Death and T cells. Immunol. Rev. 133:1993;119-129. Review.
26. McCarron R.M., Wang L., Racke M.K., McFarlin D.E., Spatz M. Cytokine-regulated adhesion between encephalogenic T lymphocytes and cerebrovascular endothelial cells. J. Neuroimmunol. 43:1993;23-30.
27. Miller J.F.A.P., Moraham G. Peripheral T cell tolerance. Annu. Rev. Immunol. 10:1992;51-70.
28. Mottram P., Han W., Purcell L., McKenzie I., Hancock W. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and IFN-γ in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation. 59:1995;559-565.
29. Nossal G.J.V. Immunologic tolerance: Collaboration between antigen and lymphokines. Science. 245:1989;147-153.
30. Pender M., McCombe P., Yoong G., Nguyen K. Apoptosis of alpha beta T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: Its possible implications for recovery and acquired tolerance. J. Autoimmun. 5:1992;401-410.
31. Peterson J.D., Karpus W.J., Clatch R.J., Miller S.D. Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus. Eur. J. Immunol. 23:1993;46-55.
32. Schluesener H.J., Wekerle H. Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: In vitro selection from unprimed rat T lymphocyte populations. J. Immunol. 135:1985;3128-3133.
33. Schmied M., Breitschopf H., Gold R., Zischler H., Rothe G., Wekerle H., Lassmann H. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am. J. Pathol. 143:1993;446-452.
34. Weiner H.L. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol. Today. 18:1997;335-343.
35. Zhang J., Markovic S., Raus J., Lacet B., Weiner H.L., Hafler D.A. Increased frequency of IL-2 responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:1993;973-984.